Adeza Sues Matria Over Marketing Test

Adeza Biomedical Corp. sued Matria Healthcare Inc., alleging that Matria has failed to comply with a contract to market its test for predicting premature births. Matria shares fell $1 to close at $4.50 in Nasdaq trading. Adeza hired Matria’s predecessor company, Tokos Medical Corp., in 1991 to market and sell its fFN Elisa test. In 1996, Tokos merged with Healthdyne Inc. to form Marietta, Ga.-based Matria. Sunnyvale-based Adeza, a closely held company, said it seeks to end the contract, but it didn’t release details of the suit it filed in Santa Clara County Superior Court. A Matria spokesman said his company has complied with all terms of the contract.